Core C will provide the personnel and expertise to conduct all the PET imaging studies and will provide the software tools and statistical support needed by the projects for data analysis. We have combined the previous data analysis core and imaging core together because of the considerable overlap of responsibilities (i.e., it is not entirely clear when image reconstruction ends and data processing begins), and because many of the data analysis tools have now been developed, with the major task now being one of practical implementation. The imaging support will include scheduling studies. patient education, patient positioning, placement of vascular catheters, injection of radiopharmaceuticals, blood sampling, assistance in gamma counting of samples and in use of the blood gas and glucose analyzers, tomographic data acquisition, image reconstruction and archiving, and all the appropriate quality control checks of the tomograph and ancillary equipment. The data analysis support will include: 1) automated preparation of blood counts and tissue region-of-interest data; 2) a general purpose program (Viewbox) for image display and manipulation; 3) a set of parameter optimization programs to model whole body blood time-activity curves; 4) a set of parameter optimization programs to model tissue uptake of each relevant radiopharmaceutical; 5) construction of metabolic images using the technique of mixture analysis; 6) optimization of simple imaging protocols to make the protocols more widely applicable; and 7) biostatistical support to help design studies, test hypotheses, and compare visual interpretation with quantitative imaging. This support is essential for the projects to ensure that the studies are done in an effective manner with valid, quantitative data analysis.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA042045-11
Application #
5207324
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
11
Fiscal Year
1996
Total Cost
Indirect Cost
Lindner, Jonathan R; Link, Jeanne (2018) Molecular Imaging in Drug Discovery and Development. Circ Cardiovasc Imaging 11:e005355
O'Sullivan, Finbarr; O'Sullivan, Janet N; Huang, Jian et al. (2018) Assessment of a statistical AIF extraction method for dynamic PET studies with 15O water and 18F fluorodeoxyglucose in locally advanced breast cancer patients. J Med Imaging (Bellingham) 5:011010
Linden, Hannah M; Peterson, Lanell M; Fowler, Amy M (2018) Clinical Potential of Estrogen and Progesterone Receptor Imaging. PET Clin 13:415-422
Link, Jeanne M; Krohn, Kenneth A; O'Hara, Matthew J (2017) A simple thick target for production of89Zr using an 11MeV cyclotron. Appl Radiat Isot 122:211-214
Wolsztynski, E; O'Sullivan, F; O'Sullivan, J et al. (2017) Statistical assessment of treatment response in a cancer patient based on pre-therapy and post-therapy FDG-PET scans. Stat Med 36:1172-1200
Kurland, Brenda F; Peterson, Lanell M; Lee, Jean H et al. (2017) Estrogen Receptor Binding (18F-FES PET) and Glycolytic Activity (18F-FDG PET) Predict Progression-Free Survival on Endocrine Therapy in Patients with ER+ Breast Cancer. Clin Cancer Res 23:407-415
Wangerin, Kristen A; Muzi, Mark; Peterson, Lanell M et al. (2017) A virtual clinical trial comparing static versus dynamic PET imaging in measuring response to breast cancer therapy. Phys Med Biol 62:3639-3655
Fowler, Amy M; Clark, Amy S; Katzenellenbogen, John A et al. (2016) Imaging Diagnostic and Therapeutic Targets: Steroid Receptors in Breast Cancer. J Nucl Med 57 Suppl 1:75S-80S
Muzi, Mark; Krohn, Kenneth A (2016) Imaging Hypoxia with ยน?F-Fluoromisonidazole: Challenges in Moving to a More Complicated Analysis. J Nucl Med 57:497-8
Currin, Erin; Peterson, Lanell M; Schubert, Erin K et al. (2016) Temporal Heterogeneity of Estrogen Receptor Expression in Bone-Dominant Breast Cancer: 18F-Fluoroestradiol PET Imaging Shows Return of ER Expression. J Natl Compr Canc Netw 14:144-7

Showing the most recent 10 out of 196 publications